The Study of Quadruple Therapy Zinc, Quercetin, Bromelain and Vitamin C on the Clinical Outcomes of Patients Infected With COVID-19
NCT04468139 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2020-07-13
Summary
There are currently no antiviral drugs with proven efficacy nor are there vaccines for its prevention. Unfortunately, the scientific community has little knowledge of the molecular details of SARS-CoV-2 infection. The drugs we are chosen are used as clinical trials for antiviral and there is no proven guide for specificity and effectiveness against the virus so the results are different Now the clinical trials and research authorities are work speedily to target the most proven treatment for the virus so anything is infantile until now. the covid-19 with time be more explained by scientists it is steroid response disease and cause thromosis and cytokine storm , the aim of the study to inhibit viral replication and decrease the severity of the disease as antiviral and anticytokine storm , antithrombosis Zinc is a mineral element needed to regulate adaptive immune cells' functions. Higher level of intracellular zinc showed to increase intracellular pH; which affect on RNA-dependent RNA polymerase and decrease replication mechanism of RNA viruses. Therefore, drugs that described as zinc ionophores could be used with zinc supplement to act as antiviral against many RNA viruses including SARS-CoV-2 Quercetin is natural compound act as zinc ionophore to cause zinc influx intracellular.
Quercetin is a safe natural anti-oxidant and anti-inflammatory polyphenolic compound that found in various natural sources include onion, red grapes, honey and citrus fruits. It was shown that quercetin has the ability to chelate zinc ions and act as zinc ionophore. Therefore, quercetin could have antiviral activity against many RNA viruses . Quercetin, a flavonoid found in fruits and vegetables, has unique biological properties that may improve mental/physical performance and reduce infection risk ; These properties form the basis for potential benefits to overall health and disease resistance, including anti-carcinogenic, anti-inflammatory, antiviral, antioxidant, and psychostimulant activities, as well as the ability to inhibit lipid peroxidation, platelet aggregation and capillary permeability, and to stimulate mitochondrial biogenesis .There are various studies that report the immunomodulatory effect of bromelain . Bromelain activates natural killer cells and augments the production of granulocyte-macrophage-colony stimulating factor, IL-2, IL-6 and decreases the activation of Thelper cells. Thus, bromelain decreases the majority of inflammatory mediators and has demonstrated a significant role as an anti-inflammatory agent in various conditions Vitamin C is known as an essential anti-oxidant.,and enzymatic co-factor for physiological reactions such as hormone production, collagen synthesis and immune potentiation . Naturally, an insufficiency of vitamin C leads to severe injuries to multiple organs, especially to the heart and brain, since they are both highly aerobic organs that produce more oxygen radicals. In fact, studies of in vivo effect on vitamin C are difficult since most animals, except human and some primate, are capable of synthesizing vitamin C endogenously
Conditions
Interventions
- DRUG
-
Quercetin
Dietary Supplement: Quercetin Treatment a daily dose of quercetin (500 mg) will be taken orally by proven COVID-19 cases intervention
- DIETARY_SUPPLEMENT
-
bromelain
Dietary Supplement:Bromealin Treatment a daily dose of bromelain(500 mg) will be taken orally by proven COVID-19 cases intervention
- DRUG
-
Zinc
zinc 50 mg orally daily dose will be taken orally by proven COVID-19 cases intervention
- DRUG
-
Vitamin C
vitamin c 1000 mg orally daily by proven COVID-19 cases intervention
Sponsors & Collaborators
-
Ministry of Health, Saudi Arabia
lead OTHER_GOV
Principal Investigators
-
Hiba Hamadelnil elsaeed · Netherlands: Ministry of Health, Welfare and Sports
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-06-20
- Primary Completion
- 2020-07-20
- Completion
- 2020-07-30
- FDA Drug
- Yes
Countries
- Saudi Arabia
Study Locations
More Related Trials
-
Efficacy and Safety of High-dose Vitamin C Combined With Chinese Medicine Against Coronavirus Pneumonia (COVID-19)
NCT04664010 ·Status: COMPLETED ·Phase: NA
-
Antioxidant Therapy for COVID-19 Study
NCT04466657 ·Status: WITHDRAWN ·Phase: NA
-
Oral Nutritional Supplements in Treatment of Elderly Mild-to-Moderate COVID-19
NCT05629975 ·Status: UNKNOWN ·Phase: NA
-
Clinical Study to Evaluate the Effect of Food Supplement in People Infected With Coronavirus
NCT05446961 ·Status: COMPLETED ·Phase: PHASE2
-
Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia
NCT04264533 ·Status: TERMINATED ·Phase: PHASE2
-
Changing of Trace Element, Homocysteine, Oxidative Stress Parameters and Physical Activity Levels in Covid-19
NCT04694703 ·Status: COMPLETED
-
Efficacy and Safety of Ozonised Oil (HOO) in COVID-19 Patients
NCT04651387 ·Status: WITHDRAWN ·Phase: NA
-
Effect of N-acetylcysteine on Oxidative Stress in COVID-19 Patients
NCT04792021 ·Status: COMPLETED ·Phase: PHASE3
-
(CBDRA60) to Prevent or Reduce Symptoms of COVID-19 and Prevention of Post-Acute Sequelae of SARS-CoV-2 Infection PASC
NCT04777981 ·Status: UNKNOWN ·Phase: NA
-
Effects of Nicotinamide Riboside on the Clinical Outcome of Covid-19 in the Elderly
NCT04407390 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effect of "Nicotinamide Mononucleotide" (NMN) on Cardiometabolic Function
NCT03151239 ·Status: COMPLETED ·Phase: NA
-
Effects of Lutein Supplementation on Oxidative Stress and Inflammation in Healthy Nonsmokers
NCT01056094 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Pharmacologic Ascorbic Acid as an Activator of Lymphocyte Signaling for COVID-19 Treatment
NCT04363216 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of Palmitoylethanolamide on Proinflammatory Markers in Adults Recently Diagnosed With COVID-19
NCT04912921 ·Status: COMPLETED ·Phase: NA
-
Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease
NCT04419025 ·Status: COMPLETED ·Phase: PHASE2
-
Use of 1-MNA to Improve Exercise Tolerance and Fatigue in Patients After COVID-19
NCT04961476 ·Status: COMPLETED
-
Randomized Proof-of-Concept Trial to Evaluate the Safety and Explore the Effectiveness of Resveratrol, a Plant Polyphenol, for COVID-19
NCT04400890 ·Status: TERMINATED ·Phase: PHASE2
-
Nicotinamide Riboside Impact on Extracellular Nicotinamide Adenine Dinucleotide (NAD+)
NCT06005350 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effect Of Calcitriol On Neutrophil To Lymphocytes Ratio And High Sensitivity C-Reactive Protein Covid-19 Patients
NCT05765617 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Tolerability of ABBC1 in Volunteers Receiving the Influenza or Covid-19 Vaccine
NCT04798677 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Effect of Nicotinamide Mononucleotide (NMN) As an Adjuvant to Standard of Care (SOC) On Fatigue Associated With COVID-19 Infection
NCT05175768 ·Status: TERMINATED ·Phase: NA
-
Coenzyme Q-10 and Pulmonary Arterial Hypertension
NCT01148836 ·Status: COMPLETED ·Phase: NA
-
Triphala Supplementation and High-intensity Interval Exercise and Immune System Function and Oxidative Stress
NCT06208761 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of a Dietary Supplementation in Reducing Hospital Admissions for COVID-19. Randomized Clinical Trial
NCT04751669 ·Status: COMPLETED ·Phase: NA
-
Role of Mega Dose of Vitamin C in Critical COVID-19 Patients
NCT04682574 ·Status: COMPLETED ·Phase: NA